Intramyometrial pregnancy is a rare form of ectopic pregnancy. It makes a diagnostic and therapeutic challenge. If misdiagnosed the intramyometrial pregnancy can cause a uterine rupture and become life-threatening condition. We report a case of intramyometrial pregnancy in twin pregnancy following IVF with spontaneous abortion of the first twin At 9 weeks of gestation. The 10 weeks scan showed a normal fetus which was described to be highly localized in the uterus but the diagnosis of intramyometrial pregnancy was not suspected. The patient was admitted at 14 weeks of gestation with pelvic pain, hemorrhage, and shock. She was operated and the diagnosis of ruptured intramyometrial pregnancy was done and managed conservatively. This case illustrates the diagnostic difficulties of intramyometrial pregnancy. We discuss pathophysiology, diagnosis, and treatment of this exceptional form of ectopic pregnancy.
L’atrésie iléale est une malformation congénitale rare, elle constitue une faible part avec une incidence de 1 pour 5000 cas. Elle peut être suspectée et diagnostiqué échographiquement à la fin du deuxième et troisième trimestre. La concertation obstétrico-chirurgicale constitue ici la clé du succès. Eliminer une maladie générale à mauvais pronostic, lutter contre la prématurité et confier l’enfant immédiatement au chirurgien sont les objectifs principaux à réaliser. L'intervention chirurgicale va préciser le type de l'atrésie, son siège, son caractère unique ou multiple et sa longueur dont l’acte chirurgical dépend de l’étiologie. Il nous a paru intéressant de vous documenter un cas clinique d’atrésie iléale de diagnostic anténatal.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.